Multicenter Phase II Clinical Trial of Isolated Lung Perfusion in Patients With Lung Metastases

Phase II Multicenter Clinical Trial of Pulmonary Metastasectomy and Isolated Lung Perfusion with Melphalan in Patients with Resectable Lung Metastases

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000279 ◽

2014 ◽

Vol 9 (10) ◽

pp. 1547-1553 ◽

Cited By ~ 13

Author(s):

Willem A. den Hengst ◽

Jeroen M.H. Hendriks ◽

Bram Balduyck ◽

Inez Rodrigus ◽

Jan B. Vermorken ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Lung Metastases ◽

Lung Perfusion ◽

Pulmonary Metastasectomy ◽

Multicenter Clinical Trial ◽

Isolated Lung Perfusion ◽

Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases☆☆☆

European Journal of Cardio-Thoracic Surgery ◽

10.1016/j.ejcts.2010.03.048 ◽

2010 ◽

Vol 38 (5) ◽

pp. 621-627 ◽

Cited By ~ 22

Author(s):

Willem A. Den Hengst ◽

Bart P. Van Putte ◽

Jeroen M.H. Hendriks ◽

Bernard Stockman ◽

Wim-Jan P. van Boven ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Lung Metastases ◽

Lung Perfusion ◽

Phase I Clinical Trial ◽

Term Survival ◽

Long Term Survival ◽

Isolated Lung Perfusion ◽

Isolated Lung Perfusion With Melphalan for Resectable Lung Metastases: A Phase I Clinical Trial

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2004.05.058 ◽

2004 ◽

Vol 78 (6) ◽

pp. 1919-1927 ◽

Cited By ~ 50

Author(s):

Jeroen M.H. Hendriks ◽

Marco J.J.H. Grootenboers ◽

Franz M.N.H. Schramel ◽

Wim J. van Boven ◽

Bernard Stockman ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Lung Metastases ◽

Lung Perfusion ◽

Phase I Clinical Trial ◽

Isolated Lung Perfusion ◽

Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model

European Journal of Cardio-Thoracic Surgery ◽

10.1093/ejcts/ezs017 ◽

2012 ◽

Vol 42 (2) ◽

pp. 341-347 ◽

Cited By ~ 6

Author(s):

W. A. Den Hengst ◽

J. M. H. Hendriks ◽

T. Van Hoof ◽

K. Heytens ◽

G. Guetens ◽

...

Keyword(s):

Pulmonary Artery ◽

Lung Metastases ◽

Lung Perfusion ◽

Rodent Model ◽

Isolated Lung Perfusion ◽

Isolated Lung ◽

Artery Perfusion

A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoring

Cancer ◽

10.1002/1097-0142(19950215)75:4<1038::aid-cncr2820750421>3.0.co;2-f ◽

1995 ◽

Vol 75 (4) ◽

pp. 1038-1044 ◽

Cited By ~ 33

Author(s):

Reinhard Dummer ◽

Günter Burg ◽

Martin E. Gore ◽

Barry W. Hancock ◽

Pierre J. Guillou ◽

...

Keyword(s):

Clinical Trial ◽

Continuous Infusion ◽

Metastatic Melanoma ◽

Phase Ii ◽

Clinical Data ◽

Phase Ii Clinical Trial ◽

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

10.1158/1538-7445.am2013-4664 ◽

2013 ◽

Cited By ~ 7

Author(s):

Edward B. Garon ◽

Jill M. Siegfried ◽

Steven M. Dubinett ◽

Robert M. Elashoff ◽

David J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Multicenter Phase ◽

Previously Treated

Interim Results of a Phase II Clinical Trial Comparing Outcomes of Recipients of Lungs Recovered from Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) Assessed by Ex-Vivo Lung Perfusion (EVLP) and CT Scan to Outcomes of Recipients of Lungs from Brain-Dead Donors (BDDs)

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2016.01.1071 ◽

2016 ◽

Vol 35 (4) ◽

pp. S372

Author(s):

T.M. Egan ◽

B. Haithcock ◽

J. Long ◽

K. Birchard ◽

J. Lobo ◽

...

Keyword(s):

Clinical Trial ◽

Ct Scan ◽

Phase Ii ◽

Ex Vivo ◽

Lung Perfusion ◽

Phase Ii Clinical Trial ◽

Determination Of Death ◽

Ex Vivo Lung Perfusion ◽

Brain Dead

Everolimus in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab and taxanes: A multicenter phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1013 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1013-1013 ◽

Cited By ~ 20

Author(s):

F. Dalenc ◽

M. Campone ◽

P. Hupperets ◽

R. O'Regan ◽

C. Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Abstract No LB12: A prospective, multicenter phase II clinical trial using irreversible electroporation for the treatment of early stage HCC

Journal of Vascular and Interventional Radiology ◽

10.1016/j.jvir.2012.05.018 ◽

2012 ◽

Vol 23 (8) ◽

pp. 1114 ◽

Cited By ~ 6

Author(s):

R. Lencioni ◽

F. Izzo ◽

L. Crocetti ◽

V. Vilgrain ◽

M. Abdel-Rehim ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Early Stage ◽

Irreversible Electroporation ◽

Phase Ii Clinical Trial ◽

A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma

Nanomedicine Nanotechnology Biology and Medicine ◽

10.1016/j.nano.2009.01.009 ◽

2009 ◽

Vol 5 (4) ◽

pp. 419-423 ◽

Cited By ~ 56

Author(s):

Qinghua Zhou ◽

Xun Sun ◽

Lingyuan Zeng ◽

Jie Liu ◽

Zhirong Zhang

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽